[Pharmacological and clinical profile of epinastine hydrochloride (Alesion Dry Syrup 1%)].
Ohmura
Tsuyoshi
T
ohmura@kaw.boehringer-ingelheim.com
Kawasaki
Tetsuo
T
D000818:Animals; D002675:Child, Preschool; D003876:Dermatitis, Atopic / Q000188:drug therapy; D003984:Dibenzazepines / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D051379:Mice; D011537:Pruritus / Q000188:drug therapy; D051381:Rats; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy
D003984:Dibenzazepines; D006634:Histamine H1 Antagonists; D007093:Imidazoles; C053090:epinastine